NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Operating Lease, Liability in USD from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Navidea Biopharmaceuticals, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2018 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Operating Lease, Liability for the quarter ending September 30, 2023 was $10.7K, a 63.2% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $10.7K -$18.3K -63.2% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $19.6K -$101K -83.8% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $11.3K -$198K -94.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $20.3K -$276K -93.1% Dec 31, 2022 10-K 2023-03-27
Q3 2022 $29K -$351K -92.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $120K -$314K -72.3% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $209K -$304K -59.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $296K -$295K -49.9% Dec 31, 2021 10-K 2022-03-28
Q3 2021 $381K -$286K -42.9% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $434K -$277K -39% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $514K -$268K -34.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $591K -$172K -22.5% Dec 31, 2020 10-K 2021-03-26
Q3 2020 $666K -$159K -19.2% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $712K -$153K -17.7% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $782K -$146K -15.8% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $763K -$236K -23.6% Dec 31, 2019 10-K 2020-03-18
Q3 2019 $825K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $865K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $928K Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $999K Jan 1, 2019 10-K 2021-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.